These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6314723

  • 21. Cyproheptadine treatment in Cushing's disease.
    Tanakol R, Alagöl F, Azizlerli H, Sandalci O, Terzioğlu T, Berker F.
    J Endocrinol Invest; 1996 Apr; 19(4):242-7. PubMed ID: 8862505
    [Abstract] [Full Text] [Related]

  • 22. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN, Valueva GV, Luchitsky EV.
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [Abstract] [Full Text] [Related]

  • 23. Cushing's disease presenting with growth failure: clinical remission during cyproheptadine therapy.
    Grant DB, Atherden SM.
    Arch Dis Child; 1979 Jun; 54(6):466-8. PubMed ID: 475431
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A case of Cushing's disease successfully treated with bromocriptine.
    Sumiya N, Hiramatsu K, Arimori S.
    Jpn J Med; 1990 Jun; 29(2):185-90. PubMed ID: 2172607
    [Abstract] [Full Text] [Related]

  • 26. Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome.
    Mercado-Asis LB, Yanovski JA, Tracer HL, Chik CL, Cutler GB.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):514-7. PubMed ID: 9024246
    [Abstract] [Full Text] [Related]

  • 27. The use of cyproheptadine (peritol) as a drug blocking corticotropin secretion in the treatment of Itsenko-Cushing's disease.
    Komissarenko IV, Cheban AK, Rybakov SI, Pomerantsev YuV, Slavnov VI, Luchitskii EV.
    Neurosci Behav Physiol; 1982 Feb; 12(6):494-6. PubMed ID: 6314174
    [No Abstract] [Full Text] [Related]

  • 28. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
    Zgliczyński S, Kozłowicz I, Wilczyńska J, Baranowska B.
    Mater Med Pol; 1980 Feb; 12(1-2):85-90. PubMed ID: 6276625
    [No Abstract] [Full Text] [Related]

  • 29. Cyproheptadine in Cushing's syndrome.
    Marek J, Matys Z, Gregorová I.
    Lancet; 1977 Sep 24; 2(8039):653-4. PubMed ID: 71464
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.
    Kennedy AL, Sheridan B, Montgomery DA.
    Acta Endocrinol (Copenh); 1978 Nov 24; 89(3):461-8. PubMed ID: 212917
    [Abstract] [Full Text] [Related]

  • 33. Effect of bromocriptine in pituitary-dependent Cushing's syndrome.
    Lamberts SW, Birkenhäger JC.
    J Endocrinol; 1976 Aug 24; 70(2):315-6. PubMed ID: 184231
    [No Abstract] [Full Text] [Related]

  • 34. Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm.
    Jordan RM, Ramos-Gabatin A, Kendall JW, Gaudette D, Walls RC.
    J Clin Endocrinol Metab; 1982 Sep 24; 55(3):531-7. PubMed ID: 6284783
    [Abstract] [Full Text] [Related]

  • 35. Cushing syndrome in dogs: treatment with bromocriptine and cyproheptadine.
    Richkind M.
    Vet Med Small Anim Clin; 1981 Sep 24; 76(9):1301-4. PubMed ID: 6277079
    [No Abstract] [Full Text] [Related]

  • 36. [Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
    Vetter W, Vetter H, Beckerhoff R, Würsten D, Siegenthaler W.
    Schweiz Med Wochenschr; 1976 Sep 25; 106(39):1320-2. PubMed ID: 1034340
    [Abstract] [Full Text] [Related]

  • 37. Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine.
    Adachi M, Takayanagi R, Yanase T, Sakai Y, Ikuyama S, Nakagaki H, Osamura Y, Sanno N, Nawata H.
    Intern Med; 1996 Mar 25; 35(3):207-11. PubMed ID: 8785455
    [Abstract] [Full Text] [Related]

  • 38. Cortisol secretory patterns in Cushing's disease and response to cyproheptadine treatment.
    van Waveren Hogervorst CO, Koppeschaar HP, Zelissen PM, Lips CJ, Garcia BM.
    J Clin Endocrinol Metab; 1996 Feb 25; 81(2):652-5. PubMed ID: 8636284
    [Abstract] [Full Text] [Related]

  • 39. Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.
    Loli P, Berselli ME, Frascatani F, Muratori F, Tagliaferri M.
    J Endocrinol Invest; 1984 Apr 25; 7(2):93-6. PubMed ID: 6327800
    [Abstract] [Full Text] [Related]

  • 40. Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
    O'Mullane N, Walker B, Jefferson J, Hipkin L, Diver M, Davis C.
    J Endocrinol Invest; 1978 Oct 25; 1(4):355-7. PubMed ID: 229153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.